Toxicoproteomics -- a new preclinical tool.
The publication of the human genome has presented the scientific community with an unprecedented amount of genetic information with the potential to revolutionize the drug discovery process. This information could be used to identify novel drug targets and disease markers or could aid in the develop...
主要な著者: | Bandara, L, Kennedy, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2002
|
類似資料
-
Toxicoproteomic Profiling of <i>hPXR</i> Transgenic Mice Treated with Rifampicin and Isoniazid
著者:: Christopher Trent Brewer, 等
出版事項: (2020-07-01) -
Digging Deeper Into the Pyriproxyfen-Response of the Amphipod Gammarus fossarum With a Next-Generation Ultra-High-Field Orbitrap Analyser: New Perspectives for Environmental Toxicoproteomics
著者:: Judith Trapp, 等
出版事項: (2018-06-01) -
Toxicoproteomics Disclose Pesticides as Downregulators of TNF-α, IL-1β and Estrogen Receptor Pathways in Breast Cancer Women Chronically Exposed
著者:: Luciana Pizzatti, 等
出版事項: (2020-08-01) -
In vitro toxicoproteomic analysis of A549 human lung epithelial cells exposed to urban air particulate matter and its water-soluble and insoluble fractions
著者:: Ngoc Q. Vuong, 等
出版事項: (2017-10-01) -
Ex Vivo Metrics™, a preclinical tool in new drug development
著者:: Bilyard Kevin, 等
出版事項: (2008-01-01)